Biotechnology patent protection: hearing before the Subcommittee on Courts, Intellectual Property, and the Administration of Justice of the Committee on the Judiciary, House of Representatives, One Hundred First Congress, second session, on H.R. 3957 and H.R. 5664 ... September 25, 1990, Volume 4
What people are saying - Write a review
We haven't found any reviews in the usual places.
September 25 1990
Armitage Robert A vice president corporate patents and trademarks
8 other sections not shown
Other editions - View all
Administration of Justice American Amgen amino acid Berman biotech biotechnological material biotechnology companies biotechnology industry biotechnology inventions Biotechnology Patent Protection Boucher bill CCPA chemical Chugai compounds Congress Court of Appeals decision DNA sequence drug enactment erythropoietin essential material existing Federal Circuit foreign competition gene Genentech genetic engineering Genetics Institute Honorable Robert importation Intellectual Property INTELLECTUAL PROPERTY OWNERS International Trade Commission inventor issue Judiciary jurisdiction Kuehl legislation Manbeck manufacture method nonobvious novel obvious Patent and Trademark patent application patent examiner Patent Office Patent Protection Act patentable material pharmaceutical Pleuddemann prior art problem process claims Process Patent Amendments process patent protection process-of-use claims product claims product patent protein recombinant rEPO retroactive Rick Boucher section 337 starting material Subcommittee on Courts Tariff Act tion title 35 trade laws Trademark Office U.S. patent law United States Code United States patent unobvious USPQ